From: Perioperative statin therapy in cardiac surgery: a meta-analysis of randomized controlled trials
Trial | Journal | Cardiac surgery procedure | Number of patients | Statin | Statin regimen | Duration of preoperative therapy | Control | Patients naïve to statin therapy? | Outcomes for meta-analysis | Risk of bias |
---|---|---|---|---|---|---|---|---|---|---|
Almansob 2012 [31] | Arterioscler Thromb Vasc Biol | Non coronary cardiac surgery | 132 | Simvastatin 20 mg | 5–7 days preop and from day 2 postop (no day 0) | 5–7 days | No treatment | NR | AF, MI, S, M | High |
Baran 2012 [32] | Stem Vell Rev and Rep | CABG | 60 | Atorvastatin 40Â mg | 2Â weeks preop and postop (no day 0) | 2Â weeks | Placebo | Yes (>3Â months) | AKI, AF, MI, S, M | High |
Berkan 2009 [33] | Thorac Cardiov Surg | CABG | 46 | Fluvastatin 80Â mg | 3Â weeks preop | 3Â weeks | Placebo | Yes (>1Â year) | MI | High |
Billings 2016 [21] | JAMA | CABG (49%), valve, or ascending aortic surgery | 615 | Atorvastatin 40 mg | Bid day 1b, qd day 0, and qd postop | 2 days | Placebo | No (Naïve 32%) | AKI, AF, MI, S, M, I | Low |
Caorsi 2008 [34] | Eur Cytokine Netw | On-pump CABG | 43 | Pravastatin 40 mg | 2 days preop, 1 hour after CPB, and 7 days postop | 2 days | No treatment | NR | AF | High |
Carrascal 2016 [51] | J Arrhythm | Valve surgery | 90 | Atorvastatin 40 mg | 7 days preop and 7 days postop | 7 days | No treatment | Yes | AKI, AF, MI, S, M | High |
Castaño 2015 [35] | J Cardiovasc Surg | On-pump CABG | 30 | Pravastatin 80 or 40 mg | 2 hours before surgery | 1 days | Placebo | No (Naïve 0%) | AF, MI, M | Unclear |
Chello 2006 [36] | Crit Care Med | On-pump CABG | 40 | Atorvastatin 20 mg | 3 weeks preop | 3 weeks | Placebo | Yes (>1 year) | AKI, AF, MI, S, M, I | Unclear |
Christenson 1999 [37] | Eur J Cardiothorac Surg | On-pump CABG | 77 | Simvastatin 20Â mg | 4Â weeks preop | 4Â weeks | No treatment | NR | AKI, MI, M, I | High |
Dehghani 2015 [38] | J Cardiovasc Pharmacol Ther | Valve surgery | 58 | Atorvastatin 40Â mg | 3Â days preop and 5Â days postop | 3Â days | Placebo | Yes | AF, MI, S, M | Unclear |
Ji 2009 [39] | Circ J | Off-pump CABG | 140 | Atorvastatin 20 mg | 7 days preop | 7 days | Placebo | Yes | AF, MI, S, M | High |
Mannacio 2008 [40] | J Thorac Cardiovasc Surg | On-pump CABG | 200 | Rosuvastatin 20 mg | 7 days preop | 7 days | Placebo | Yes (>1 month) | AKI, AF, MI, S, M, I | High |
Melina 2009 [41]a | Eur Heart J | On- off-pump CABG | 632 | Atorvastatin 40 mg | NR | NR | Placebo | NR | AF | High |
Park 2016 [42] | Intensive Care Med | Valve surgery | 200 | Atorvastatin 40 mg | Bid day 1, qd day 0, and qd 3 days postopb | 2 days | Placebo | Yes | AKI, AF, MI, S, M | Unclear |
Patti 2006 [43] | Circulation | On-pump cardiac surgery (CABG 79%) | 200 | Atorvastatin 40 mg | 7 days preop and postop until discharge (no day 0) | 7 days | Placebo | Yes (>1 year) | AF, MI, M | High |
Prowle 2012 [44] | Nephrology | On-pump cardiac surgery (CABG 57%) | 100 | Atorvastatin 40 mg | Days 0 and 3 days postop | 1 days | Placebo | No (Naïve 30%) | AKI, M | Low |
Song 2008 [45] | Am Heart J | Off-pump CABG | 124 | Atorvastatin 20Â mg | 3Â days preop, after surgery, and 30Â days postop | 3Â days | No treatment | Yes | AF, MI, S | High |
Spadaccio 2010 [46] | J Cardiovasc Pharmacol | On-pump CABG | 50 | Atorvastatin 20 mg | 3 weeks preop | 3 weeks | Placebo | Yes (>1 year) | AKI, AF, MI, S, M, I | Unclear |
Sun 2011 [47] | Int Heart J | On-pump CABG | 100 | Atorvastatin 20 mg | 7 days preop | 7 days | Placebo | Yes (>14 days) | AF, MI | High |
Tamayo 2009 [50] | J Thorac Cardiovasc Surg | On-pump CABG | 44 | Simvastatin 20 mg | 3 weeks preop | 3 weeks | No treatment | Yes (>3 weeks) | AF, M | High |
Vukovic 2011 [48] | Perfusion | On-pump CABG | 57 | Atorvastatin 20Â mg | 3Â weeks preop | 3Â weeks | Placebo | Yes (>1Â year) | AF, MI, M, I | High |
Youn 2011 [49] | Korean J Thorac Cardiovasc Surg | Off-pump CABG | 142 | Rosuvastatin 20 mg | Bid day 1, qd day 0 | 2 days | No treatment | No (Naïve 45%) | MI, M | High |
Zheng 2016 [22] | N Engl J Med | On-pump CABG (42%), off-pump CABG (43%), AVR, AVR + CABG | 1922 | Rosuvastatin 20 mg | 1–8 days preop and 5 days postop | 8 days | Placebo | No (Naïve 66%) | AKI, AF, MI, S, M, I | Low |